Heritability estimates across all genes in each cancer type. Cis-locus was defined as +/-500kb of the gene boundary. Samples were restricted to Europeans by principal components analysis. All models were adjusted for 20 gene expression PCs, 2 genetic ancestry PCs, and local structural variation estimated from a SNP array in the tumor. Heritability was estimated using GCTA/REML.
N samples: number of samples; N genes: number of converged genes with heritabiliy estimates; hsq: mean heritability estimate; hsq (se): standard error of the mean heritability estimate; hsq P<0.01: number of genes with heritability p-value < 0.01 (computed by likelihood ratio test), representing nominally predictive models.
Label | Cancer | N samples | N genes | hsq | hsq (se) | hsq P<0.01 |
---|---|---|---|---|---|---|
TCGA-BLCA.TUMOR | Bladder Urothelial Carcinoma | 380 | 16249 | 0.0157 | 0.0003 | 1677 |
TCGA-BRCA.TUMOR | Breast Invasive Carcinoma | 1049 | 16633 | 0.0188 | 0.0003 | 4464 |
TCGA-CESC.TUMOR | Cervical Squamous Cell Carcinoma | 277 | 16224 | 0.0194 | 0.0004 | 1117 |
TCGA-COAD.TUMOR | Colon Adenocarcinoma | 275 | 16253 | 0.0275 | 0.0005 | 2098 |
TCGA-ESCA.TUMOR | Esophageal Carcinoma | 170 | 16468 | 0.0218 | 0.0007 | 697 |
TCGA-GBM.TUMOR | Glioblastoma Multiforme | 125 | 16090 | 0.0317 | 0.0007 | 1039 |
TCGA-HNSC.TUMOR | Head and Neck Squamous Cell Carcinoma | 499 | 16586 | 0.0190 | 0.0003 | 2763 |
TCGA-KIRC.TUMOR | Kidney Renal Clear Cell Carcinoma | 506 | 16608 | 0.0297 | 0.0005 | 4139 |
TCGA-KIRP.TUMOR | Kidney Renal Papillary Cell Carcinoma | 283 | 16098 | 0.0286 | 0.0005 | 2080 |
TCGA-LGG.TUMOR | Brain Lower Grade Glioma | 483 | 16695 | 0.0316 | 0.0005 | 4347 |
TCGA-LIHC.TUMOR | Liver Hepatocellular Carcinoma | 352 | 15593 | 0.0213 | 0.0005 | 1121 |
TCGA-LUAD.TUMOR | Lung Adenocarcinoma | 500 | 16636 | 0.0195 | 0.0003 | 2973 |
TCGA-LUSC.TUMOR | Lung Squamous Cell Carcinoma | 464 | 16781 | 0.0169 | 0.0003 | 2544 |
TCGA-OV.TUMOR | Ovarian Serous Cystadenocarcinoma | 284 | 16671 | 0.0184 | 0.0004 | 1620 |
TCGA-PAAD.TUMOR | Pancreatic Adenocarcinoma | 172 | 16532 | 0.0325 | 0.0006 | 1685 |
TCGA-PCPG.TUMOR | Pheochromocytoma and Paraganglioma | 175 | 15962 | 0.0291 | 0.0006 | 1342 |
TCGA-PRAD.TUMOR | Prostate Adenocarcinoma | 468 | 16634 | 0.0366 | 0.0005 | 4675 |
TCGA-READ.TUMOR | Rectum Adenocarcinoma | 89 | 15954 | 0.0330 | 0.0009 | 707 |
TCGA-SARC.TUMOR | Soft Tissue Sarcoma | 249 | 15966 | 0.0159 | 0.0004 | 1091 |
TCGA-SKCM.TUMOR | Skin Cutaneous Melanoma | 103 | 15538 | 0.0231 | 0.0007 | 541 |
TCGA-STAD.TUMOR | Stomach Adenocarcinoma | 387 | 16654 | 0.0182 | 0.0004 | 1718 |
TCGA-TGCT.TUMOR | Testicular Germ Cell Tumors | 149 | 15675 | 0.0304 | 0.0007 | 1296 |
TCGA-THCA.TUMOR | Thyroid Carcinoma | 484 | 16454 | 0.0456 | 0.0006 | 5211 |
TCGA-UCEC.TUMOR | Uterine Corpus Endometrial Carcinoma | 171 | 15980 | 0.0197 | 0.0007 | 518 |